Friday, May 13, 2011

Poniard cuts Q1 loss to $3.3M

Poniard Pharmaceuticals Inc. lost $3.3 million in the first quarter.
A year earlier in the same quarter the San Francisco company (NASDAQ: PARD) lost $12.5 million.
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)